Showing results (81-90 of 506) with videos related to
Sort By:
Pageof 51
The Canadian Journal of Cardiology|December 25, 2012
Genetics of coagulation: what the cardiologist needs to knowJulia A Anderson, Wendy Lim, Jeffrey I WeitzArteriosclerosis, Thrombosis, and Vascular Biology|March 21, 2015
Overview of the new oral anticoagulants: opportunities and challengesCalvin H Yeh, Kerstin Hogg, Jeffrey I WeitzSmall (Weinheim an Der Bergstrasse, Germany)|November 28, 2019
Lubricant-Infused PET Grafts with Built-In Biofunctional Nanoprobes Attenuate Thrombin Generation and Promote Targeted Binding of CellsMaryam Badv, Jeffrey I Weitz, Tohid F DidarChest|September 24, 2004
New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJeffrey I Weitz, Jack Hirsh, Meyer M SamamaNature Reviews. Cardiology|January 19, 2018
Reversal agents for non-vitamin K antagonist oral anticoagulantsJerrold H Levy, James Douketis, Jeffrey I WeitzJournal of Thrombosis and Haemostasis : JTH|February 18, 2026
Formation of a ternary polyphosphate-thrombin-fibrin complex attenuates thrombin activityXintong Yao, James C Fredenburgh, Jeffrey I WeitzHematology/Oncology Clinics of North America|September 18, 2016
The Intrinsic Pathway of Coagulation as a Target for Antithrombotic TherapyAllison P Wheeler, David GailaniExpert Review of Hematology|August 29, 2009
Update on the physiology and pathology of factor IX activation by factor XIaStephen B Smith, David GailaniClinical Pharmacokinetics|December 17, 2008
Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in developmentBengt I Eriksson, Daniel J Quinlan, Jeffrey I WeitzEuropean Heart Journal|March 29, 2023
Reversal agents for current and forthcoming direct oral anticoagulantsNick van Es, Raffaele De Caterina, Jeffrey I WeitzPageof 51